BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.710
-0.080 (-2.87%)
Aug 7, 2026, 4:00 PM EDT - Market closed
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $13.11 million as of August 10, 2026. Its market cap has decreased by -23.51% in one year.
Market Cap
13.11M
Enterprise Value
8.77M
1-Year Change
-23.51%
Ranking
Category
Stock Price
$2.71
ChartMarket Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $13.11M, a decrease of -80.88%. That is a compound annual growth rate of -10.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 13.11M | 0.09% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 14.65M |
| Passage Bio | 14.11M |
| Palatin Technologies | 14.02M |
| KALA BIO | 13.90M |
| Chemomab Therapeutics | 13.90M |
| Psyence Biomedical | 13.24M |
| SeaStar Medical Holding | 13.19M |
| Akari Therapeutics, | 12.25M |